The groundbreaking rise of Viagra has consistently remained a example of pharmaceutical success, however its position within the broader market now triggers questions about potential yields . Copycat versions are eroding exclusivity , leading to worries that investing in companies closely tied to Viagra's former position could be a problematic deci